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23 of 29 patients of CRT group, at least 4 courses of CT were 
performed to 57% patients. Median overall survival, 1-year survival, 
and the rate of distant metastases at 1 year were 16 vs 11 (95% CI, 10-
13)months, p=0.174; 69% (95% CI, 52%-86%) vs 46% (95% CI, 28%-64%), 
and 45% vs60%, p=0.301, respectively. 
 
  
Conclusions: The trend towards better survival and lower rate of 
distant metastases for CRT comparing to CT in ILAGC has been 
revealed. Further recruitment to this randomized study is warranted. 
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Background: - Local recurrence is a major problem after rectal cancer 
surgery. Local recurrence rates historically vary between 15% and 45%. 
The introduction of total mesorectal excision (TME) as treatment for 
patients with rectal cancer has led to an improved local control and 
survival when compared with historical controls. 
Purpose:  To analyze local recurrence rates in our patients treated 
with preoperative radiotherapy with/without chemotherapy followed 
by TME or non TME surgery. 
Materials and Methods: Two hundred fifty patients(pts) were enrolled 
between January 2004 and December 2010. Median age was 62 years 
(min=26, max=83). There were 83 female and 167 male. To be 
eligible, patients had to have histologically confirmed 
adenocarcinoma of the rectum, without evidence of distant 
metastases, and the inferior margin of the tumor had to be located 
not farther than 15 cm from the anal verge. Initially, 96% of patients 
had locally advanced stage of disease (T3/T4N0, any TN+). All patients 
had preoperative radiotherapy (RT) with/without chemotherapy (5-
fluorouracil or capecitabine). The patients assigned to preoperative 
RT received a total dose of 45-50.4Gy in 25-28 fractions for 5 to 5.5 
weeks followed by TME (118 pts) or non TME surgery (132 pts). The 
overall recurrence rate and the recurrence rates from different 
surgical approaches were calculated in our retrospective analysis. 
Also, we evaluated influence of tumor distance from the anal verge, 
dose of irradiation, type of chemotherapy, postoperative stage of 
disease, resection margins, presence of lymph–angioinvasion and KRAS 
mutation status on the rate of local recurrence (LR).  
Results: Median follow-up time was 48 months (range, 12 to 
96months). The cumulative proportion of local recurrence was 6.8% 
for all group of patients (0.8% in the group with TME and 6% in the 
group with non TME, p=0.0022, Fisher‘s exact test). 
The 5 year DFS was 86% in the group of pts with TME and 71% in the 
group with non TME (p=0.0025). The 5 year OS was 87% in the group of 
pts with TME and 77% in the group with non TME (p=0.0012). There 
was very statistically significant difference between two groups of pts 
regarding DFS and OS. 
Conclusions: Radiotherapy followed by TME has been shown to 
significantly reduce local recurrence rates in our patients. The strong 
criteria for identifying low risk group of pts for LR were: TME and 
negative resection margins (p=0.0009).  
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Purpose/Objective: NHL arises often in extra nodal tissues. 
Gastrointestinal lymphoma represents the largest group of extra nodal 
lymphoma. It accounts for approximately 40 percent of them. The 
most frequent type of non-Hodgkin's lymphoma is diffuse large-B-cell 
lymphoma. More than half of patients with diffuse large-B-cell 
lymphoma are over 60 years of age and the treatment of these elderly 
patients is a difficult challenge. 
Materials and Methods: This study included 18 patients from 2008 to 
2010 of age more than 60 years. All patients were subjected to six 
cycles of R CHOP followed by involved field radiotherapy. Radiation 
(45 Gy /25#/5 weeks) was given with linear accelerator(energies used 
6, 15 MV) by 3DCRT technique. With Keeping in mind the toxicities 
associated with these drugs and the KPS of the patient, drug dosage 
was reduced. In most cases it was reduced by 20-25%. 
Results: The completion rate of patients with this regimen was 100%. 
5 year local control rate was 96%. Five year disease free survival was 
74%. Grade III neurotoxicity was seen in one patient. 
Conclusions: The concept of chemotherapy with reduced dosage 
followed by involved field radiotherapy is safe and effective in 
managing the Gastric lymphomas even in patients with associated 
geriatric co morbidities.  
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Purpose/Objective: We are conducting a simultaneous integrated 
boost (SIB) method using volumetric modulated arc therapy (VMAT)-
intensity- modulated radiotherapy (IMRT) in preoperative 
chemoradiation for locally-advanced rectal cancer. We report the 
initial experience in our department. 
Materials and Methods: The object is rectal cancer with invasion to 
the Rb (rectum below the peritoneal reflection) in stages II-III. It 
started to register from January, 2012. It is finished in 16 cases up to 
operative treatment (Total Mesorectal Excision) as of October. In the 
supine position, 45Gy/25Fr to the whole pelvis and 55Gy/25Fr to the 
gross tumor volume were given using SIB method of VMAT-IMRT. The 
combined chemotherapy is multiple drug combination including 
UFT(tegafur-uracil) + UZEL ± CPT-11. 
Results: The anal preservation rate was 13/16 case. In the grade by 
the histologic effect measurement criteria, grade 1 was 8 cases, grade 
2 was 2 cases, and grade 3 (= complete response) was 3 cases. The 
response rate was 47% and it was a good result. The frequency of 
diarrhea during radiotherapy was low. 
Conclusions: It is a treatment method tolerated enough. It continues 
as this regimen. 
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Purpose/Objective: To evaluate the series of patients treated with 
adjuvant- or salvage-External Beam Radiotherapy (EBRT) after radical 
prostatectomy (RP) in localized prostate cancer, and to revise the 
derivation criteria from the urology departments.  
Materials and Methods: A total of 159 patients diagnosed from 
localized prostate cancer, remitted from 4 different urology 
departments, were included retrospectively in the study. Patients 
were treated with radical prostatectomy and posterior EBRT, and 
were recruited from 2007 to 2012. Clinical and pathological data were 
colleted, including the risk group (before and after RT), parameters 
needed for the decision of treatment selection (adjuvant vs. rescue), 
time to androgen deprivation and dose administered in RT. Response 
to EBRT in terms of BFFS was also evaluated, defining biochemical 
failure as PSA level post-EBRT > 0.20 ng/ml.  
Results: Mean Age: 60.9y (SD: 6.5). Pre-RP Risk Group: Low: 28 
(17.61%), intermediate: 69 (43.39%), high 27 (16.98%) and unknown 35 
(22.01%). Post-RP Risk Group: Low: 5 (3.14%), intermediate: 38 
(23.90%), high: 109 (68.55%) and unknown: 7 (4.40%). Margin status: 
Positive: 93 (58.49%), negative: 54 (33.96%) and unknown 12 (7.54%). 
